PTCT
#1229
PTC Therapeutics, Inc. - Common Stock
71.8 1 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.21%
Monthly Change
-4.06%
6 month change
+7.05%
Year Change
+44.14%
Previous Close
72.6 9
Open
71.8 1
Low
71.8 1
High
71.8 1
Volume
77
Financials
- Market Capitalization 5.99 B
- Employee 991
- Founded 1998
- CEO Matthew B. Klein
- Website www.ptcbio.com
- Headquarter Delaware, United States
- FIGI BBG000QT15P7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
9.76
Price to sales ratio
3.88
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1209 |  BLTE Belite Bio Inc - American Depositary Shares | 157.01 USD | +0.20% | -3.97% | +2.48% | +146.10% | 6.18 B USD | ||
| 1228 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 61.93 USD | -2.92% | +2.45% | -5.19% | +51.83% | 6.00 B USD | ||
| 1245 |  DFTX Definium Therapeutics, Inc. - Common Shares | 43.82 USD | +0.11% | -4.51% | +4.33% | +190.01% | 5.89 B USD | ||
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD |
Frequently asked questions about PTC Therapeutics, Inc.
What is the PTC Therapeutics, Inc. stock price today?
The current price of PTC Therapeutics, Inc. (PTCT) is 71.81. Over the past 24 hours, the stock has changed by -1.21%. Follow the PTCT chart for real-time price dynamics.
What is the stock ticker of PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. trades under the ticker PTCT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is PTC Therapeutics, Inc. stock going up?
PTCT has changed by +1.80% over the last week, -4.06% over the last month, and +44.14% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of PTC Therapeutics, Inc.?
PTC Therapeutics, Inc. currently has a market capitalization of 5.99 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were PTC Therapeutics, Inc. earnings last quarter?
Last quarter, PTC Therapeutics, Inc. reported earnings of 1.01 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was PTC Therapeutics, Inc. revenue for the last quarter?
PTC Therapeutics, Inc. reported quarterly revenue of 360.52 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was PTC Therapeutics, Inc. net income for the last quarter?
PTC Therapeutics, Inc. reported net income of 83.5 M for the last quarter. The previous quarter showed -2.81 M, which means net income changed by +3072.45%.
How many employees does PTC Therapeutics, Inc. have?
As of the latest available data, PTC Therapeutics, Inc. has 991 employees. Workforce size can provide additional context about the company's scale and operations.
What is PTC Therapeutics, Inc. EBITDA?
PTC Therapeutics, Inc. EBITDA is 163.95 M, and its EBITDA margin is 45.48%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy PTC Therapeutics, Inc. stock?
You can buy PTC Therapeutics, Inc. (PTCT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in PTC Therapeutics, Inc. stock?
Investing in PTC Therapeutics, Inc. requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PTCT chart and related analysis on metatrader.com as part of your research.